Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $8.04 | $1.88 |
| Change | -0.20 (-2.43%) | 0.12 (6.82%) |
| Market Cap | $0.93B | $0.57B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.46 | -2.76 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $28.25 | $2.46 |
| 52-Week Low | $5.90 | $0.85 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-4.25 | $-2.13 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | -67.29% | -26.98% | -43.78% | -76.55% | -63.62% | -63.62% |
| PACB | 2.17% | 3.87% | 4.44% | -87.41% | -81.42% | -81.42% |